Following a healthy response to the IPO of Emcure Pharmaceuticals, the shares of the company are commanding a healthy premium of Rs 360 in the unlisted market.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Following a healthy response to the IPO of Emcure Pharmaceuticals, the shares of the company are commanding a healthy premium of Rs 360 in the unlisted market.
| Subscribe To Our Free Newsletter |
